Effect of liposomal formulations and immunostimulating peptidoglycan monomer (PGM) on the immune reaction to ovalbumin in mice

Journal of Liposome Research

Volumn 16, Issue 1, 2006, Pages 1-16

  Habjanec, Lidija ^a   Frkanec, Ruža ^a   Halassy, Beata ^a   Tomašić, Jelka ^a  

^a INSTITUTE OF IMMUNOLOGY   (Croatia)

Author keywords

IgG; IgG1 and IgG2a subclasses; Liposomes; Ovalbumin; Peptidoglycan monomer

Indexed keywords

FREUND ADJUVANT; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2A ANTIBODY; IMMUNOSTIMULATING AGENT; LIPOSOME; OVALBUMIN; PEPTIDOGLYCAN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; DRUG POTENTIATION; ENCAPSULATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNE RESPONSE; IMMUNITY; IMMUNOSTIMULATION; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; TH1 CELL; TH2 CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; LIPOSOMES; MICE; MICE, INBRED CBA; OVALBUMIN; PEPTIDOGLYCAN; TH1 CELLS; TH2 CELLS;

EID: 33645338707     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.1080/08982100500528537     Document Type: Article

References (54)

1. Allison, A.C., Byars, N.E. (1986). An adjuvant formulation that selectively elicits the formulation of antibodies of protective isotypes and of cell-mediated immunity. J. Immunol. Meth. 95(2): 157-168.
2. Alving, C.R. (1991). Liposomes as carriers of antigens and adjuvants. J. Immunol. Meth. 140:1-13.
3. Alving, C.R., Koulchin, V., Glenn, G.M., Rao, M. (1995). Liposomes as carriers of peptide antigens: induction of antibodies and cytotoxic T lymphocytes to conjugated and unconjugated peptides. Immunol. Rev. 145:5-31.
4. Alving, C.R., Richards, R.L. (1990). Liposomes cointaining lipid A: a potent nontoxic adjuvant for a human malaria sporozoite vaccine. Immunol. Lett. 25:275-280.
5. Antimisiaris, S.G., Jayasekera, P., Gregoriadis, G. (1993). Liposomes as vaccine carriers. Incorporation of soluble and particulate antigens in giant vesicles. J. Immunol. Meth. 166:271-280.
6. Aramaki, Y., Suda, H., Tsuchiya, S. (1995). Interferon-γ inductive effect of liposomes as an immunoadjuvant. Vaccine 13(18):1809-1814.
7. Baca-Estrada, M.E., Foldvari, M., Snider, M. (1999). Induction of mucosal immune responses by administration of liposome-antigen formulations and interleukin-12. J. Interferon Cytokine Res. 19:455-462.
8. Brynestad, K., Babbit, B., Huang, L., Rouse, B.T. (1990). Influence of peptide acylation, liposome incorporation, and synthetic immunomodulators on the immunogenicity of a 1-23 peptide of glycoprotein D of herpes simplex virus: implications for subunit vaccine. J. Virol. 64(2):680-685.
9. Bui, T., Dykers, T., Hu, S.L., Faltynek, C.R., Ho, R.J. (1994). Effect of MTP-PE liposomes and interleukin-7 on induction of antibody and cell-mediated immune responses to a recombinant HIV-envelope protein. J. Acquir. Immune Defic. Syndr. 7(8):799-806.
10. Childers, N.K., Miller, K.L., Tong, G., Llarena, J.C., Greenway, T., Ulrich, J.T., Michalek, S.M. (2000). Adjuvant activity of monophosphoryl lipid A for nasal and oral immunization with soluble or liposome-associated antigen. Infect. Immun. 68(10):5509-5516.
11. Copland, M.J., Baird, M.A., Rades, T., McKenzie, J.L., Becker, B., Reck, F., Tyler, P.C., Davies, N.M. (2003). Liposomal delivery of antigen to human dendritics cells. Vaccine 21:883-890.
12. Davis, D., Gregoriadis, G. (1989). Primary immune response to liposomal tetanus toxoid in mice: the effect of mediators. Immunology 68(2):277-282.
13. de Haan, A., Geerlings, H.J., Huchshorn, J.P., van Scharrenburg, G.J.M., Palache, A.M., Wilschut, J. (1995). Mucosal immunoadjuvant activity of liposomes: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with an influenza subunit vaccine and coadministered liposomes. Vaccine 13(2):55-162.
14. Foged, C., Arigita, C., Sundblad, A., Jiskoot, W., Storm, G., Frokjaer, S. (2004). Interaction of dendritic cells with antigen-containing liposomes: effect of bilayer composition. Vaccine 22:1903-1913.
15. Fortin, A., Lagace, J., Therien, H.M. (2001). Trafficking of surface-linked and encapsulated liposomal antigens in macrophages: an immunocytohemical study. J. Histochem. Cytohem. 49(11):1407-1420.
16. Frkanec, R., Noething-Laslo, V., Vranešić, B., Mirosavljević, K., Tomašić, J. (2003). A spin labeling study of immunomodulating peptidoglycan monomer and adamantyltripeptides entrapped into liposomes. Biochim. Biophys. Acta. 1611:187-196.
17. Frkanec, R., Travaš, D., Krstanović, M., Hallasy Špoljar, B., Ljevaković, Crossed D sign., Vranešić, B., Frkanec, L., Tomašić, J. (2003). Entrapment of peptidoglycans and adamantyltripeptides into liposomes: An HPLC assay for determination of encapsulation efficiency. J. Liposom. Res. 13(3&4):279-294.
18. Gianan, M.A.V., Kleinerman, E.S. (1998). Liposomal muramyl tripeptide (CGP 19835A lipid) therapy for resectable melanoma patients who were at high risk for relapse: an update. Cancer Biother. Radiopharm. 13(5):363-368.
19. Gregoriadis, G. (1990). Immunological adjuvants: a role for liposomes. Immunol. Today 11(3):89-97.
20. Gregoriadis, G., McCormack, B., Obrenovic, M., Perrie, Y., Saffie, R. (2000). Liposomes as immunological adjuvants and vaccine carriers. In: O'Hagan, D.T., ed. Vaccine Adjuvants: Preparation Methods and Research Protocols. New York, Totowa: Humana Press Inc., pp. 137-150.
21. Gregoriadis, G., Panagiotidi, C. (1989). Immunodjuvant action of liposomes: comparison with other adjuvants. Immunol. Lett. 20(3):237-240.
22. Halassy, B., Krstanović, M., Frkanec, R., Tomašić, J. (2003). Adjuvant activity of peptidoglycan monomer and its metabolic products. Vaccine 21:971-976.
23. Halassy Špoljar, B., Čimbora, T., Hanzl-Dujmović, I., Dojnović, B., Sabioncello, A., Krstanović, M., Tomašić, J. (2002). Influence of adjuvant-active peptidoglycan monomer on specific T cell responses in mice. Vaccine 20:3543-3550.
24. Harding, C.V., Collins, D.S., Kanagawa, O., Unanue, E.R. (1999). Liposome-encapsulated antigens engender lysosomal processing for class II MHC presentation and cytosolic processing for class I presentation. J. Immunol. 147(9):2860-2863.
25. Hayashi, A., Nakanishi, T., Kunisawa, J., Kondoh, M., Imazu, S., Tsutsumi, Y., Tanaka, K., Fujiwara, H., Hamaoka, T., Mayumi, T. (1999). A novel vaccine delivery system using immunopotentating fusogenic liposomes. Biochem. Biophys. Res. Commun. 261(3):824-828.
26. Iinuma, H., Nerome, K., Yoshioka, Y., Okinaga, K. (1995). Characteristics of cytotoxic T-lymphocytes directed to influenza virus haemagglutinin elicited by immunization with muramyl dipeptide-influenza liposome vaccine. Scand. J. Immunol. 41:1-10.
27. Keglević, D., Ladešić, B., Tomašić, J., Valinger, Z., Naumski, R. (1979). Isolation procedure and properties of monomer unit from lysozyme digest of peptidoglycan complex excreted into the medium by penicillin-treated Brevibacterium divaricatum mutant. Biochim Biophys Acta 585:273-281.
28. Killion, J.J., Fidler, L.J. (1998). Therapy of cancer metastasis by tumoricidal activation of tissue macrophages using liposome-encapsulated immunomodulators. Pharmacol. Therap. 78(3):141-154.
29. Kim, C.K., Jeong, E.J., Kim, M.H. (2000). Comparison of in vivo fate and immunogenicity of hepatitis B surface antigen incorporated in cationic and neutral liposomes. J. Microencap. 17(3):297-306.
30. Lian, T., Ho, R.J.H. (2001). Trends and developments in liposome drug delivery systems. J. Pharmac. Sci. 90(6):667-680.
31. Lipford, G.B., Wagner, H., Heeg, K. (1994). Vaccination with immunodominant peptides encapsulated in QuilA-cointaining liposomes induces peptide-specific primary CD8+ cytotoxic T cells. Vaccine 12:73-80.
32. Ljevaković, Crossed D sign., Tomašić, J., Šporec, V., Halassy Špoljar, B., Hanzl-Dujmović, I. (2000). Synthesis of novel adamantylacetyl derivate of peptidoglycan monomer-biological evaluation of immunomodulatory peptidoglycan monomer and respective derivates with lipophilic substituents on amino group. Bioorg. Med. Chem. 8:2441-2447.
33. Maassen, C.B.M., Boersma, W.J.A., van Holten-Neelen, C., Claassen, E., Laman, J.D. (2003). Growth phase of orally administered Lactobacillus strains differentially affects IgG1/IgG2a ratio for soluble antigens: implications for vaccine development. Vaccine 21:2751-2757.
34. MacEwen, E.G., Kurzman, I.D., Vail, D.M., Dubielzig, R.R., Everlith, K., Madewell, B.R., Rodriguez, C.O., Jr., Phillips, B., Zwahlen, C.H., Obradovich, J., Rosenthal, R.C., Fox, L.E., Rosenberg, M., Henry, C., Fidel, J. (1999). Adjuvant therapy for melanoma in dogs: results of randomized clinical trials using surgery, liposome-encapsulated muramyl tripeptide, and granulocyte macrophage colony-stimulating factor. Clin. Cancer Res. 5:4249-4258.
35. Mackova, N.O., Fedoročko, P. (2002). Effect of liposomal muramyl tripeptide phosphatidylethanolamine and indomethacin on hematopoietic recovery in irradiated mice. Physiol. Res. 51:511-521.
36. Matter, H., Szilagyi, L., Forgo, P., Marinić, Ž., Klaić, B. (1997). Structure and dynamics of a peptidoglycan monomer in aqueous solution using NMR spectroscopy and stimulated annealing calculations. J. Amer. Chem. Society 119:2212-2223.
37. Mazumdar, T., Anam, K., Ali, N. (2004). A mixed Th1/Th2 response elicited by liposomal formulation of Leishmania vaccine instructs Th1 responses and resistance to Leishmania donovani in susceptible BALB/c mice. Vaccine 22:1162-1171.
38. Mosmann, T.R., Coffman, R.L. (1989). Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145-173.
39. Phillips, N.C., Gagne, L., Ivanoff, N., Riveau, G. (1996). Influence of phospholipid composition on antibody responses to liposome encapsulated protein and peptide antigens. Vaccine 14(9):898-904.
40. Reddy, R., Zhou, F., Nair, S., Huang, L., Rouse, B.T. (1992). In vivo cytotoxic T lymphocyte induction with soluble proteins administered in liposomes. J. Immunol. 148(5):1585-1589.
41. Serre, K., Giraudo, L., Henri, S., Machy, P., Leserman, L. (2003). Dendritic cells capture and efficiently present antigen encapsulated in liposomes to T cells in vivo. J. Liposom. Res. 13(1):27-29.
42. Shek, P.N., Sabiston, B.H. (1982). Immune response mediated by liposome-associated protein antigens. Immunology 45:349-356.
43. Sprott, G.D., Dicaire, C.J., Gurnani, K., Sad, S., Krishnan, L. (2004). Activation of dendritic cells by liposomes prepared from phosphatidylinositol mannosides from Mycobacterium bovis Bacillus Calmette-Guerin and adjuvant activity in vivo. Infect. Immun. 72(9):5235-5246.
44. Stewart-Tull, D.E.S. (1989). Recommendations for the assessment of adjuvants (immunopotentiators). In: Gregoriadis, G., Allison, A.C., Poste, G., eds. Immunological adjuvants and Vaccines. New York: Plenum Publishing Corporation, pp. 213-226.
45. Tanaka, Y., Kasai, M., Teneichi, M., Naito, S., Kato, H., Mori, M., Nishida, M., Maekawa, N., Yamamura, H., Komuro, K., Uchida, T. (2004). Liposomes with differential lipid components exert differential adjuvanticity in antigen-liposome conjugates via differential recognition by macrophages. Bioconjug. Chem. 15(1):35-40.
46. Tomašić, J., Hanzl-Dujmović, I., Špoljar, B., Vranešić, B., Šantak, M., Jovičić, A. (2000). Comparative study of the effects of peptidoglycan monomer and structurally related adamantyltripeptides on humoral immune response to ovalbumin in the mouse. Vaccine 18:1236-1243.
47. 14C)peptidoglycan monomer into liposomes. Effect on metabolism and immune response in mice. Biochim. Biophys. Acta 716:217-223.
48. Tomašić, J., Sesartić, Lj., Martin, S.A., Valinger, Z., Ladešić, B. (1988). Comparative susceptibility of a peptidoglycan monomer from Brevibacterium divaricatum and its anhydromuramyl analogue to hydrolysis with N-acetylmuramyl-L-alanine-amidase. J. Chromatog. 440:405-414.
49. Tsujimoto, M., Kotani, S., Okunaga, T., Kubo, T., Takada, H., Kubo, T., Shiba, T., Kusumoto, S., Takahashi, T., Goto, Y. (1989). Enhancement of humoral immune response against viral vaccine by a non-pyrogenic 6-O- acylmuramyldipeptide and sythetic low toxicity analogues of lipid A. Vaccine 7(1):39-48.
50. Turanek, J., Toman, M., Novak, J., Krchnak, V., Horavova, P. (1994). Adjuvant effect of liposomes and adamantylamide dipeptide on antigenicity of entrapped synthetic peptide derived from HIV-1 transmembrane region glycoprotein gp 41. Immunol. Lett. 39(2):157-161.
51. Ullrich, S.E., Fidler, I.J. (1992). Liposomes cointaining muramyl tripeptide phosphatidiylethanolamine (MTP-PE) are excellent adjuvants for induction of an immune response to protein and tumor antigens. J. Leukoc. Biol. 52(5):489-494.
52. van Rooijen, N., van Nieuwmegen, R. (1980). Liposomes in immunology: evidence that their adjuvant effect results from surface exposition of the antigens. Cellular Immunol. 49:402-407.
53. van Slooten, M.L., Hayon, I., Babai, I., Zakay-Rones, Z., Wagner, E., Storm, G., Kedar, E. (2001). Immunoadjuvant activity of interferon-γ- liposomes co-administered with influenza vaccines. Biochim. Biophys. Acta 1531:99-110.
54. White, W.I., Cassat, D.R., Madsen, J., Burke, S.J., Woods, R.M., Wassef, N.M., Alving, C.R., Koenig, S. (1995). Antibody and cytotoxic T-lymphocyte responses to a single liposome-associated peptide antigen. Vaccine 13(12):1111-1122.